Bekris Stathis, Antoniou Katerina, Daskas Spyros, Papadopoulou-Daifoti Zeta
Department of Experimental Pharmacology, Medical School, University of Athens, M. Asias 75, Goudi, 11527 Athens, Greece.
Behav Brain Res. 2005 Jun 3;161(1):45-59. doi: 10.1016/j.bbr.2005.01.005. Epub 2005 Feb 1.
Chronic mild stress (CMS) has been reported to induce an anhedonic-like state in rats that resembles some of the symptoms of endogenous depression in humans. In the present study, CMS-induced behavioural responses along with neurochemical alterations in dopaminergic and serotonergic function in prefrontal cortex, striatum, hypothalamus and hippocampus were examined following treatment with imipramine in Wistar and Sprague-Dawley rats. The CMS procedure lasted 7 weeks in total. Once per week, a 1-h preference test for 1% sucrose solution was conducted. Treatment with imipramine (10mg/kg i.p., once daily) commenced after experimental week 3. CMS induced significant reductions in absolute and relative sucrose intake and sucrose preference in both rat strains but their temporal pattern was different especially during the weeks 0-3. These effects were reversed by IMI. An increase in the dopaminergic and a decrease in the serotonergic activity were observed in the prefrontal cortex in both rat strains following CMS. A decrease in the striatal dopaminergic activity and an increased hippocampal serotonergic activity were also seen in both rat strains following CMS. In Wistar rats, dopaminergic and serotonergic activities were enhanced in the hypothalamus whereas in Sprague-Dawley rats no such stress-induced changes were observed. Notably, the clear decrease in sucrose consumption observed in stressed Wistar rats could be directly associated with a respective increase in the dopaminergic hypothalamic activity. Chronic treatment with imipramine normalized all neurochemical alterations induced by CMS. Our results suggest that a specific and regionally differentiated serotonin-dopamine interaction is directly related to the observed stress-induced anhedonia.
据报道,慢性轻度应激(CMS)会在大鼠中诱发一种类似快感缺失的状态,类似于人类内源性抑郁症的一些症状。在本研究中,对Wistar和Sprague-Dawley大鼠用丙咪嗪治疗后,检测了CMS诱导的行为反应以及前额叶皮质、纹状体、下丘脑和海马体中多巴胺能和5-羟色胺能功能的神经化学改变。CMS程序总共持续7周。每周进行一次1%蔗糖溶液的1小时偏好测试。在实验第3周后开始用丙咪嗪(10mg/kg腹腔注射,每日一次)治疗。CMS导致两种大鼠品系的绝对和相对蔗糖摄入量以及蔗糖偏好显著降低,但它们的时间模式不同,尤其是在第0 - 3周。这些效应被丙咪嗪逆转。CMS后,两种大鼠品系的前额叶皮质中多巴胺能活性增加,5-羟色胺能活性降低。CMS后,两种大鼠品系的纹状体多巴胺能活性降低,海马体5-羟色胺能活性增加。在Wistar大鼠中,下丘脑的多巴胺能和5-羟色胺能活性增强,而在Sprague-Dawley大鼠中未观察到这种应激诱导的变化。值得注意的是,在应激的Wistar大鼠中观察到的蔗糖消耗明显减少可能与下丘脑多巴胺能活性的相应增加直接相关。丙咪嗪的慢性治疗使CMS诱导的所有神经化学改变恢复正常。我们的结果表明,一种特定的、区域分化的5-羟色胺-多巴胺相互作用与观察到的应激诱导的快感缺失直接相关。